Rare disease, as the name suggests, affects a small proportion of the population and appears with low prevalence. The limited number of patients impedes development of new therapies, reducing the pool of clinical trial candidates and the size of the end market. A surprising figure is that the average rare disease has a population below … Continue reading A Noble Pursuit: Gene Therapy for Rare Disease